Thursday, June 15, 2017 5:28:20 PM
Finally got through to Tilden and we had a nice conversation. Basically, DTCC lifted the global freeze - as we know now.
Company was getting orders throughout Chill period, though at a lower rate then before.
Since DTCC resumption, he has been working on catching up with complainces of OTC Market through "Transfer Agent", and other matters with CA and NV compliances. Once "everything is completed", company can move forward.
He stated reference (2015 news release) proposed merger(s), as noted by StockM they did not materialize.
He stated he will be putting out a news release, noting the DTCC resumption and, basically they are still in business and haven't gone anywhere. Adding he wanted to wait until some of the compliances are finalized.
Before we ended the conversation he stated, he was enthusiastic with developments and future the of Ingen.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM